prikaz prve stranice dokumenta The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression
Rad dostupan nakon 2024-05-01
Znanstveni rad - Izvorni znanstveni rad
The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression
Expert Review of Molecular Diagnostics, 23 (2023), 4; 283-296. https://doi.org/10.1080/14737159.2023.2200937
Nikolac Perković, Matea; Gredičak, Martin; Šagud, Marina; Nedić Erjavec, Gordana; Uzun, Suzana; Pivac, Nela

Institucijski repozitorij: Dr Med - digitalni repozitorij Medicinskog fakulteta Sveučilišta u Zagrebu

Citirajte ovaj rad

Nikolac Perković, M., Gredičak, M., Šagud, M., Nedić Erjavec, G., Uzun, S. i Pivac, N. (2023). The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression. Expert Review of Molecular Diagnostics, 23. (4), 283-296. doi: 10.1080/14737159.2023.2200937

Nikolac Perković, Matea, et al. "The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression." Expert Review of Molecular Diagnostics, vol. 23, br. 4, 2023, str. 283-296. https://doi.org/10.1080/14737159.2023.2200937

Nikolac Perković, Matea, Martin Gredičak, Marina Šagud, Gordana Nedić Erjavec, Suzana Uzun i Nela Pivac. "The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression." Expert Review of Molecular Diagnostics 23, br. 4 (2023): 283-296. https://doi.org/10.1080/14737159.2023.2200937

Nikolac Perković, M., et al. (2023) 'The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression', Expert Review of Molecular Diagnostics, 23(4), str. 283-296. doi: 10.1080/14737159.2023.2200937

Nikolac Perković M, Gredičak M, Šagud M, Nedić Erjavec G, Uzun S, Pivac N. The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression. Expert Review of Molecular Diagnostics [Internet]. 14.04.2023. [pristupljeno 30.04.2024.];23(4):283-296. doi: 10.1080/14737159.2023.2200937

M. Nikolac Perković, M. Gredičak, M. Šagud, G. Nedić Erjavec, S. Uzun i N. Pivac, "The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression", Expert Review of Molecular Diagnostics, vol. 23, br. 4, str. 283-296, Travanj 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:267765. [Citirano: 30.04.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:267765
Podaci o radu
Naslov (engleski)The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression
AutorMatea Nikolac Perković
AutorMartin Gredičak
AutorMarina Šagud
AutorGordana Nedić Erjavec
AutorSuzana Uzun
AutorNela Pivac
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA PSIHIJATRIJU I PSIHOLOŠKU MEDICINU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Psihijatrija
Sažetak (engleski)
Introduction: Recent evidence from the studies evaluating the association between brain-derived neurotrophic factor (BDNF) concentration/levels, BDNF Val66Met (rs6265) polymorphism, and major depressive disorders, referred as depression, and the association between BDNF levels and/or BDNF Val66Met with the treatment response in depression is presented. Areas covered: This mini review focuses on the changes in the peripheral BDNF levels in blood (serum, plasma, platelets) in patients with depression before or after treatment with antidepressant drugs or different therapeutic strategies. In addition, this review describes the recent data on the possible association between different antidepressants/therapeutic strategies and the particular BDNF Val66Met genotypes, evaluating the risk alleles associated with the response in patients with depression. Expert opinion: BDNF has an important role in the pathophysiology and treatment response in depression. Most data reveal that peripheral BDNF levels are lower before than after antidepressant treatment and might be used as potential biomarkers of therapeutic response. Novel therapeutic strategies should target restoring/increasing BDNF levels.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeZavršna verzija rukopisa prihvaćena za objavljivanje (postprint)
Naslov časopisaExpert Review of Molecular Diagnostics
Brojčani podacivol. 23, br. 4, str. 283-296
p-ISSN1473-7159
e-ISSN1744-8352
DOIhttps://doi.org/10.1080/14737159.2023.2200937
URN:NBNurn:nbn:hr:105:267765
Datum objave publikacije2023-04-14
URL dokumentahttps://www.tandfonline.com/doi/full/10.1080/14737159.2023.2200937
Vrsta resursaTekst
Prava pristupaPristup ograničen embargom
Datum isteka embarga: 2024-05-01
Uvjeti korištenjaIkona licence Imenovanje-Nekomercijalno 4.0 međunarodna (CC BY-NC 4.0)
Datum i vrijeme pohrane2024-01-08 08:42:18